Khosla Surgical Industries Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 02-07-2024
- Paid Up Capital ₹ 0.34 M
as on 02-07-2024
- Company Age 44 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.70 Cr
as on 02-07-2024
- Satisfied Charges ₹ 1.00 Cr
as on 02-07-2024
- Revenue 503.33%
(FY 2023)
- Profit 280.21%
(FY 2023)
- Ebitda 18.38%
(FY 2023)
- Net Worth 2.84%
(FY 2023)
- Total Assets 0.39%
(FY 2023)
About Khosla Surgical Industries
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.34 M.
The company currently has active open charges totaling ₹14.70 Cr. The company has closed loans amounting to ₹1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Neeru Tarneja and Nisha Khosla serve as directors at the Company.
- CIN/LLPIN
U33110MH1980PTC023139
- Company No.
023139
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Sep 1980
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Khosla Surgical Industries?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeru Tarneja  | Director | 01-Dec-2004 | Current |
| Nisha Khosla | Director | 01-Dec-2004 | Current |
Financial Performance of Khosla Surgical Industries.
Khosla Surgical Industries Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 503.33% increase. The company also saw a substantial improvement in profitability, with a 280.21% increase in profit. The company's net worth moved up by a moderate rise of 2.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Khosla Surgical Industries?
In 2023, Khosla Surgical Industries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹147.00 M
₹10.00 M
Charges Breakdown by Lending Institutions
- Others : 12.20 Cr
- Hdfc Bank Limited : 2.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jan 2024 | Others | ₹4.70 Cr | Open |
| 29 Jan 2024 | Others | ₹4.70 Cr | Open |
| 29 Jan 2024 | Others | ₹2.80 Cr | Open |
| 16 Jun 2014 | Hdfc Bank Limited | ₹2.50 Cr | Open |
| 28 Mar 2012 | Bank Of India | ₹1.00 Cr | Satisfied |
How Many Employees Work at Khosla Surgical Industries?
Unlock and access historical data on people associated with Khosla Surgical Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Khosla Surgical Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Khosla Surgical Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
